Research Article
Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients
Table 6
Multiple RAVs to DAAs.
| | Drug resistance mutations | | HCV gene |
| | L31M + H58P | 1 | NS5A | | Q80K + Q30R | 53 | NS3/4A + NS5A | | Q80K + Q30R + L31M | 1 | NS3/4A + NS5A | | L31M + H58P + I482L + V494A + V499A | 1 | NS5A + NS5B | | H58P + I482L + V499A | 1 | NS5A + NS5B | | Q80K + Q30R + A15G + S282T | 2 | NS3/4A + NS5A + NS5B | | Q80K + Q30R + H58P | 2 | NS3/4A + NS5A + NS5B | | Q80K + Q30R + S282T | 13 | NS3/4A + NS5A + NS5B | | Q80K + Q30R + S96T | 1 | NS3/4A + NS5A + NS5B | | Q80K + D168E + Q30R + S282T | 1 | NS3/4A + NS5A + NS5B | | Q80K + Q30R + I482L + V499A | 1 | NS3/4A + NS5A + NS5B |
|
|
